The CDC updates vaccine schedules, emphasizing personalized decision-making for COVID-19 shots and recommending standalone ...

In this interview, Steven Buslovich, M.D., CMD, MS, CMO of Senior Care at PointClickCare describes AI’s role in care ...

Medicare beneficiaries face confusion during the Annual Enrollment Period, with significant plan changes ahead for 2026.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Panelists discuss how the GALAXI-2 and GALAXI-3 trials represented a landmark study design for Crohn’s disease research ...

The differing regulation of key fibrotic pathways suggest that idiopathic pulmonary fibrosis involves dysregulation rather ...

Researchers in one study found that semaglutide may indirectly improve adherence to antipsychotic therapy for those with ...

Repatha (evolucumab) is now avaliable at a discounted cash price through Amgen's new direct-to-patient program, AmgenNow, and ...

Zoryve cream gains FDA approval for treating mild to moderate atopic dermatitis in young children, offering a safe, ...

At first, it was tentative. But now almost all parts of the U.S. healthcare system are racing to adopt some form of ...

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

An engineered CD40 antibody that can bind to a specific immune receptor and directly injected into tumors has demonstrated in a phase 1 trial that it can trigger a systemic immune response.